A wide variety of important topics will be covered including biomarker identification and validation strategies, bioinformatics and systems biology approaches to personalized medicine, big data management, regulatory and reimbursement trends, companion diagnostics development, and, finally, funding and investment opportunities. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.